Senolytic and NAD-boosting combination extended mouse lifespan by 33%
In mice, an oral combination of quercetin, NR, urolithin A and alpha-lipoic acid, started at 18 months of age, increased median remaining survival by 33%. The results are early and do not show an effect in people.
Source: Senolytic and NAD-boosting combo extended mouse lifespan by 33% (x.com). Summary written with AI from the source and reviewed by rules; read the original.
What the research shows
A study in mice tested an oral combination of quercetin, NR, urolithin A and alpha-lipoic acid, started at 18 months of age. According to the study, the combination increased median remaining survival by 33%. The animals were fed a Western high-fat diet.
The context matters. Animal research is an early step, and results in mice do not show whether the same approach would work in people. Senolytics and NAD precursors are areas of intense research, but they do not yet have an established use for extending human lifespan. Studies like this help form hypotheses, which must be tested in clinical trials before any conclusion can be drawn.
What it means
The result suggests that combinations of compounds linked to cellular aging may influence lifespan in mice. It is still unknown whether the effect would occur in people, or what the long-term safety would be.
How to read it with care
This result does not replace a medical consultation. Anyone considering changes to diet, supplements or treatment should talk to a doctor or another qualified health professional.